KR850001230A - 옥타펩티드 바조프레신 길항물질의 제조방법 - Google Patents
옥타펩티드 바조프레신 길항물질의 제조방법 Download PDFInfo
- Publication number
- KR850001230A KR850001230A KR1019840000736A KR840000736A KR850001230A KR 850001230 A KR850001230 A KR 850001230A KR 1019840000736 A KR1019840000736 A KR 1019840000736A KR 840000736 A KR840000736 A KR 840000736A KR 850001230 A KR850001230 A KR 850001230A
- Authority
- KR
- South Korea
- Prior art keywords
- pro
- phe
- tyr
- arg
- formula
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims 14
- 239000005557 antagonist Substances 0.000 title 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 claims 6
- OUYCCCASQSFEME-MRVPVSSYSA-N D-tyrosine Chemical compound OC(=O)[C@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-MRVPVSSYSA-N 0.000 claims 5
- 125000000174 L-prolyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])[C@@]1([H])C(*)=O 0.000 claims 5
- 150000001875 compounds Chemical class 0.000 claims 5
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- -1 D-Chg Chemical compound 0.000 claims 3
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims 3
- 125000006239 protecting group Chemical group 0.000 claims 3
- SNDPXSYFESPGGJ-UHFFFAOYSA-N 2-aminopentanoic acid Chemical compound CCCC(N)C(O)=O SNDPXSYFESPGGJ-UHFFFAOYSA-N 0.000 claims 2
- SNDPXSYFESPGGJ-SCSAIBSYSA-N D-2-aminopentanoic acid Chemical group CCC[C@@H](N)C(O)=O SNDPXSYFESPGGJ-SCSAIBSYSA-N 0.000 claims 2
- AGPKZVBTJJNPAG-RFZPGFLSSA-N D-Isoleucine Chemical group CC[C@@H](C)[C@@H](N)C(O)=O AGPKZVBTJJNPAG-RFZPGFLSSA-N 0.000 claims 2
- ONIBWKKTOPOVIA-SCSAIBSYSA-N D-Proline Chemical compound OC(=O)[C@H]1CCCN1 ONIBWKKTOPOVIA-SCSAIBSYSA-N 0.000 claims 2
- ROHFNLRQFUQHCH-RXMQYKEDSA-N D-leucine Chemical group CC(C)C[C@@H](N)C(O)=O ROHFNLRQFUQHCH-RXMQYKEDSA-N 0.000 claims 2
- KDXKERNSBIXSRK-RXMQYKEDSA-N D-lysine Chemical compound NCCCC[C@@H](N)C(O)=O KDXKERNSBIXSRK-RXMQYKEDSA-N 0.000 claims 2
- FFEARJCKVFRZRR-SCSAIBSYSA-N D-methionine Chemical compound CSCC[C@@H](N)C(O)=O FFEARJCKVFRZRR-SCSAIBSYSA-N 0.000 claims 2
- 125000001711 D-phenylalanine group Chemical group [H]N([H])[C@@]([H])(C(=O)[*])C([H])([H])C1=C([H])C([H])=C([H])C([H])=C1[H] 0.000 claims 2
- 125000002849 D-tyrosine group Chemical group [H]N([H])[C@@]([H])(C(=O)[*])C([H])([H])C1=C([H])C([H])=C(O[H])C([H])=C1[H] 0.000 claims 2
- KZSNJWFQEVHDMF-SCSAIBSYSA-N D-valine Chemical group CC(C)[C@@H](N)C(O)=O KZSNJWFQEVHDMF-SCSAIBSYSA-N 0.000 claims 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims 2
- 150000001718 carbodiimides Chemical class 0.000 claims 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- 229940124280 l-arginine Drugs 0.000 claims 2
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims 1
- ODKSFYDXXFIFQN-SCSAIBSYSA-N D-arginine Chemical compound OC(=O)[C@H](N)CCCNC(N)=N ODKSFYDXXFIFQN-SCSAIBSYSA-N 0.000 claims 1
- 125000000180 D-prolyl group Chemical group N1[C@@H](C(=O)*)CCC1 0.000 claims 1
- 108010016626 Dipeptides Proteins 0.000 claims 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical group F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 150000001408 amides Chemical group 0.000 claims 1
- 229940024606 amino acid Drugs 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 claims 1
- 125000002993 cycloalkylene group Chemical group 0.000 claims 1
- 238000010511 deprotection reaction Methods 0.000 claims 1
- YAGKRVSRTSUGEY-UHFFFAOYSA-N ferricyanide Chemical compound [Fe+3].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] YAGKRVSRTSUGEY-UHFFFAOYSA-N 0.000 claims 1
- 229910000040 hydrogen fluoride Inorganic materials 0.000 claims 1
- 229910052740 iodine Inorganic materials 0.000 claims 1
- 239000011630 iodine Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000001590 oxidative effect Effects 0.000 claims 1
- 108090000765 processed proteins & peptides Proteins 0.000 claims 1
- 235000019260 propionic acid Nutrition 0.000 claims 1
- 239000011347 resin Substances 0.000 claims 1
- 229920005989 resin Polymers 0.000 claims 1
- 238000007363 ring formation reaction Methods 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/16—Oxytocins; Vasopressins; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/15—Oxytocin or vasopressin; related peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Emergency Protection Circuit Devices (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (14)
- 식(I)의 화합물을 제조하는 방법 :여기에서, P는 Phe 또는 Phe(4-Alk)이고, X는 D-Phe, D-Val, D-Leu, D-Ile, D-Nva, D-Pba, D-alIe, D-Nle, D-Cha, D-Abu, D-Met, D-Chg, D-Tyr, L-Tyr, D-Tyr(Et) 또는 L-Try(alK)이고, Y는 NH2, NHAlK, NHBzl 또는 OH이고, W는 D-Pro, L-Pro, 디하이드로-Pro 또는 Y 및 Z가 없을 경우에는 CH일 수 있고, A는 Val, Ile,Abu,Ala,Gly, Lys, Cha, Nle, Phe, Leu, Chg 또는 Nva이고, Z는 D-Arg, L-Arg, D-Lys, L-Lys 또는 Y가 OH인 경우에 단일 결합일 수 있고, n는 0,1 또는 2이거나, 약학적으로 허용되는 대용약제 또는 그 염이고, 선택적으로 보호된 식(II)의 화합물을 환식화하는 것을 포함함;여기에서, X,P,A,W,Z 및 Y는 상기에서 정의된 바와같고, Q1및 Q2는 각각 수소 또는 치환가능한 그룹이고, Cap는 β-위치에 부착된 S-Q1을 가지는 β,β-씨클로알킬렌 프로피온산이고, 씨클로알킬렌고리에서 5-7단위체를 가지고 있으며, 필요하면 그 후에 어떤 순서로든지, (a) 어떤 보호하는 그룹을 제거하고, (b) 이른바 Cys(CH)6또는 Pro(OH)7화합물이 존재하면, 산으로 보호된 형태나 아미드 형태로 각각 디펩티드, W-Z-Y 또는 아미노산, Z-Y와 반응시키거나 또는 (c) 약학적으로 허용되는 염이나 대용약제를 형성시킴.
- 청구범위 제1항에서, Q1및 Q2가 둘다 수소인 경우의 방법.
- 청구범위 제1항에서, Q1및 Q2가 둘다 아세트아미도메틸인 경우의 방법.
- 청구범위 제1항 내지 제3항에서, 산화하는 환식화를 포함하는 방법.
- 청구범위 제4항에서, 요오드 존재시에 실시되는 방법.
- 청구범위 제4항에서, 훼리시아나이드 존재시에 실시되는 방법.
- 청구범위 제1항에서, 선택적으로 어떤 보호그룹을 제거시킨후에 식 I의 Cys(OH)6화합물을 카보디이미드 존재하에 (NH2)-W-Z-Y로써 반응시키는 방법.
- 청구범위 제1항에서, 선택적으로 어떤 보호하는 그룹을 제거시킨후에, 식 I의 Pro(OH)7화합물을 카보디이미드 존재하에 (NH)2-Z-Y로써 반응시키는 방법.
- 청구범위 제8항에서, Pro(OH)7을 Arg(NH2)나 그 염으로써 반응시키는 방법.
- 청구범위 제1항에서, n가 1, X가 D-Tyr(Et), P가 Phe, A가 Val, W가 Pro, Z가 Arg 및 Y가 NH2인 경우의 방법.
- 청구범위 제4항에서, n가 1, X가 D-Tyr(Et), P가 Phe 또는 Phe(4'-Et), A가 Val 또는 Abu, W가 L-Pro 또는 D-Pro, Z가 Arg 그리고 Y가 NH2인 경우의 방법.
- 식 II의 화합물을 제조하는 방법;여기에서, P는 Phe 또는 Phe(4'-Alk)이고, X가 D-Phe, D-Val, D-Leu, D-Ile, D-Nva, D-Pba, D-Alle, D-Nle, D-Cha, D-Abu, D-Met, D-Chg, D 또는 L-Tyr 또는 D 또는 L-Tyr(alK)이고, Y가 NH2, NHAlK, NHBzl 또는 OH이고, W는 D-Pro, L-Pro 디하이드로-Pro 또는, Y 및 Z가 없는 경우에 OH이고, A는 Val, Ile, Abu, Ala, Gly, LyS, Cha, Nle, Phe, Leu, Chg 또는 Nva이고, Z가 D-Arg, L-Arg, D-Lys, L-Lys 또는 Y가 OH인 경우에 단일 결합이거나 약학적으로 허용되는 그 염이고, 이것이 식 II의 화합물의 보호된 유도체를 보호 해제하는 것을 포함함.
- 청구범위 제12항에서, 식 II의 펩티드가 또는 지지하는 수지로 부터 분리된 경우의 방법.
- 청구범위 제12항 또는 제13항에서, 보호해제 시약이 불화수소인 경우의 방법.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US467117 | 1983-02-16 | ||
US06/467,117 US4469679A (en) | 1983-02-16 | 1983-02-16 | Octapeptide vasopressin antagonists |
Publications (1)
Publication Number | Publication Date |
---|---|
KR850001230A true KR850001230A (ko) | 1985-03-16 |
Family
ID=23854436
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019840000736A KR850001230A (ko) | 1983-02-16 | 1984-02-16 | 옥타펩티드 바조프레신 길항물질의 제조방법 |
Country Status (20)
Country | Link |
---|---|
US (2) | US4469679A (ko) |
EP (1) | EP0119705B1 (ko) |
JP (1) | JPS59155348A (ko) |
KR (1) | KR850001230A (ko) |
AT (1) | ATE46174T1 (ko) |
AU (1) | AU577778B2 (ko) |
DE (1) | DE3479664D1 (ko) |
DK (1) | DK65284A (ko) |
ES (2) | ES8606408A1 (ko) |
FI (1) | FI840577A (ko) |
GR (1) | GR81786B (ko) |
HU (1) | HU196227B (ko) |
IE (1) | IE56859B1 (ko) |
IL (1) | IL70944A (ko) |
NO (1) | NO840563L (ko) |
NZ (1) | NZ207106A (ko) |
PH (1) | PH20076A (ko) |
PT (1) | PT78094B (ko) |
ZA (1) | ZA841104B (ko) |
ZW (1) | ZW1884A1 (ko) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2708547A (en) * | 1950-07-19 | 1955-05-17 | Semt | Exhaust gas turbo-blowers for high supercharging rates and method of mounting same |
US4649130A (en) * | 1984-01-26 | 1987-03-10 | Medical College Of Ohio | Novel derivatives of arginine vasopressin antagonists |
US4714696A (en) * | 1984-01-26 | 1987-12-22 | Medical College Of Ohio | Novel derivatives of arginine vasopressin antagonists |
US4599324A (en) * | 1984-11-21 | 1986-07-08 | Smithkline Beckman Corporation | V1-vasopressin antagonists |
US4684716A (en) * | 1984-12-14 | 1987-08-04 | Smithkline Beckman Corporation | Polypeptide intermediates |
US4624943A (en) * | 1985-03-20 | 1986-11-25 | Smithkline Beckman Corporation | Aromatic basic-tailed vasopressin antagonists |
US4656248A (en) * | 1985-04-23 | 1987-04-07 | Smithkline Beckman Corporation | Cupric oxidation of 1,6-dimercapto-containing peptides |
US4711877A (en) * | 1985-09-18 | 1987-12-08 | Smithkline Beckman Corporation | 6-pen-vasopressin compounds |
US4742154A (en) * | 1985-10-23 | 1988-05-03 | Smithkline Beckman Corporation | GLN- or ASN-vasopressin compounds |
US4687758A (en) * | 1985-11-19 | 1987-08-18 | Smithkline Beckman Corporation | Des-proline-N-methylarginine vasopressins |
US4760052A (en) * | 1986-01-16 | 1988-07-26 | Smithkline Beckman Corporation | 1,6-dicarba-vasopressin compounds |
US4876243A (en) * | 1986-02-25 | 1989-10-24 | Smithkline Beckman Corporation | Vasopressin compounds |
US4717715A (en) * | 1986-06-23 | 1988-01-05 | Smithkline Beckman Corporation | ARG7 -ARG8 -vasopressin antagonists |
US4724229A (en) * | 1986-09-30 | 1988-02-09 | Smithkline Beckman Corporation | Arg-arg-arg-vasopressin antagonists |
US4766108A (en) * | 1986-12-04 | 1988-08-23 | Smith Kline Beckman Corporation | Tyr-Arg-vasopressin antagonists |
US4826813A (en) * | 1987-05-21 | 1989-05-02 | Smithkline Beckman Corporation | 4'-Methyl-β-mercapto-β,β-cyclopentamethylenepropionic acid vasopressin antagonists |
US5055448A (en) * | 1987-06-25 | 1991-10-08 | Medical College Of Ohio | Linear derivatives of arginine vasopressin antagonists |
JP2542241B2 (ja) * | 1988-08-12 | 1996-10-09 | 富士レビオ株式会社 | ペプチド |
US5051400A (en) * | 1990-06-28 | 1991-09-24 | Smithkline Beecham Corporation | Method of treating nausea and emesis related to motion sickness with vasopressin antagonists |
US6759384B1 (en) | 1994-04-26 | 2004-07-06 | Aventis Pharmaceuticals Inc. | Factor Xa inhibitors |
US5849510A (en) * | 1994-04-26 | 1998-12-15 | Selectide Corporation | Factor Xa inhibitors |
CA2186497C (en) * | 1994-04-26 | 2008-06-17 | Fahad Al-Obeidi | Factor xa inhibitors |
US6001809A (en) * | 1994-07-11 | 1999-12-14 | Elan Pharmaceuticals, Inc. | Inhibitors of leukocyte adhesion |
IL138214A0 (en) * | 1998-03-09 | 2001-10-31 | Zealand Pharmaceuticals As | Pharmacolgically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
US9744239B2 (en) | 2015-01-30 | 2017-08-29 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9925233B2 (en) | 2015-01-30 | 2018-03-27 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9687526B2 (en) | 2015-01-30 | 2017-06-27 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9750785B2 (en) | 2015-01-30 | 2017-09-05 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9937223B2 (en) | 2015-01-30 | 2018-04-10 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
US9744209B2 (en) | 2015-01-30 | 2017-08-29 | Par Pharmaceutical, Inc. | Vasopressin formulations for use in treatment of hypotension |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1246055A (en) * | 1980-03-24 | 1988-12-06 | Joseph H. Cort | N-.omega.-substituted hormonogens of vasopressin and its synthetic analogs |
US4399125A (en) * | 1981-03-24 | 1983-08-16 | Maurice Manning | Novel antagonists of the antidiuretic action of arginine vasopressin |
US4367225A (en) * | 1981-03-24 | 1983-01-04 | The Medical College Of Ohio | Novel antagonists of the antidiuretic and/or vasopressor action of arginine vasopressin |
US4643520A (en) * | 1983-03-10 | 1987-02-17 | Allied Corporation | Method of terminating fiber optic connector without polishing optical fiber |
-
1983
- 1983-02-16 US US06/467,117 patent/US4469679A/en not_active Expired - Fee Related
-
1984
- 1984-02-03 DE DE8484300692T patent/DE3479664D1/de not_active Expired
- 1984-02-03 EP EP84300692A patent/EP0119705B1/en not_active Expired
- 1984-02-03 AT AT84300692T patent/ATE46174T1/de active
- 1984-02-10 NZ NZ207106A patent/NZ207106A/en unknown
- 1984-02-13 IL IL70944A patent/IL70944A/xx unknown
- 1984-02-13 ZW ZW18/84A patent/ZW1884A1/xx unknown
- 1984-02-13 AU AU24534/84A patent/AU577778B2/en not_active Ceased
- 1984-02-13 PT PT78094A patent/PT78094B/pt not_active IP Right Cessation
- 1984-02-13 PH PH30237A patent/PH20076A/en unknown
- 1984-02-13 GR GR73789A patent/GR81786B/el unknown
- 1984-02-14 FI FI840577A patent/FI840577A/fi not_active Application Discontinuation
- 1984-02-14 DK DK65284A patent/DK65284A/da not_active Application Discontinuation
- 1984-02-15 ES ES529738A patent/ES8606408A1/es not_active Expired
- 1984-02-15 ZA ZA841104A patent/ZA841104B/xx unknown
- 1984-02-15 JP JP59027986A patent/JPS59155348A/ja active Pending
- 1984-02-15 IE IE352/84A patent/IE56859B1/en unknown
- 1984-02-15 HU HU84597A patent/HU196227B/hu not_active IP Right Cessation
- 1984-02-15 NO NO840563A patent/NO840563L/no unknown
- 1984-02-16 KR KR1019840000736A patent/KR850001230A/ko not_active Application Discontinuation
- 1984-06-26 US US06/624,542 patent/US4542124A/en not_active Expired - Fee Related
- 1984-09-12 ES ES535842A patent/ES8600216A1/es not_active Expired
Also Published As
Publication number | Publication date |
---|---|
US4542124A (en) | 1985-09-17 |
NO840563L (no) | 1984-08-17 |
NZ207106A (en) | 1990-12-21 |
HU196227B (en) | 1988-10-28 |
IE56859B1 (en) | 1992-01-01 |
JPS59155348A (ja) | 1984-09-04 |
ES529738A0 (es) | 1986-04-01 |
FI840577A (fi) | 1984-08-17 |
DE3479664D1 (en) | 1989-10-12 |
ES535842A0 (es) | 1985-10-01 |
US4469679A (en) | 1984-09-04 |
IE840352L (en) | 1984-08-16 |
ATE46174T1 (de) | 1989-09-15 |
FI840577A0 (fi) | 1984-02-14 |
IL70944A (en) | 1990-11-29 |
IL70944A0 (en) | 1984-05-31 |
ZA841104B (en) | 1985-04-24 |
DK65284A (da) | 1984-08-17 |
DK65284D0 (da) | 1984-02-14 |
ES8600216A1 (es) | 1985-10-01 |
ES8606408A1 (es) | 1986-04-01 |
ZW1884A1 (en) | 1984-05-30 |
PT78094B (en) | 1986-05-20 |
GR81786B (ko) | 1984-12-12 |
EP0119705A2 (en) | 1984-09-26 |
PT78094A (en) | 1984-03-01 |
EP0119705A3 (en) | 1987-04-22 |
AU577778B2 (en) | 1988-10-06 |
PH20076A (en) | 1986-09-18 |
HUT34042A (en) | 1985-01-28 |
EP0119705B1 (en) | 1989-09-06 |
AU2453484A (en) | 1984-08-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR850001230A (ko) | 옥타펩티드 바조프레신 길항물질의 제조방법 | |
AU612054B2 (en) | Peptides having bradykinin antagonist action | |
US4261886A (en) | Peptides having thymopoietin-like activity | |
KR850006941A (ko) | 데스-프로린 바조프레신 길항제의 제조방법 | |
GB1570210A (en) | Peptides | |
EP0018182B1 (en) | Peptides having thymopoietin-like activity, therapeutic compositions containing them, and process for their preparation | |
US4397842A (en) | Peptides having thymopoietin-like activity | |
US5648333A (en) | Peptides having bradykinin antagonist action | |
US4139504A (en) | Novel nonapeptides, intermediates therefor, and compositions and methods employing said nonapeptides | |
KR850002834A (ko) | 염기성 헵타 펩타이드 바조프레신 길항근의 제조방법 | |
US4127540A (en) | Novel derivatives of δ-endorphins, intermediates therefor, and compositions and methods employing said derivatives | |
US4127532A (en) | Novel heptapeptides, intermediates therefor, and compositions and methods employing said heptapeptides | |
US4127527A (en) | Novel pentadecapeptides, intermediates therefor, and compositions and methods employing said pentadecapeptides | |
US4127528A (en) | Novel derivatives of alpha-endorphin, intermediates therefor and compositions and methods employing said derivatives | |
US4127538A (en) | Novel pentacosapeptides, intermediates therefor and pharmaceutical compositions and methods employing said pentacosapeptides | |
US4127523A (en) | Novel undecapeptides, intermediates therefor, and compositions and methods employing said undecapeptides | |
US4127525A (en) | Novel tridecapeptides, intermediates therefor, and compositions and methods employing said tridecapeptides | |
US4127539A (en) | Novel hexacosapeptides, intermediates therefore and pharmaceutical compositions and methods employing said hexacosapeptides | |
US4127541A (en) | Novel decapeptides, intermediates therefor, and compositions and methods employing said decapeptides | |
US4127519A (en) | Octadecapeptides, intermediates therefor, and compositions and methods employing said octadecapeptides | |
US4127520A (en) | Novel nonadecapeptides, intermediates therefor, and compositions and methods employing said nonadecapeptides | |
US4127521A (en) | Novel octacosapeptides, intermediates therefor and pharmaceutical compositions and methods employing said octacosapeptides | |
US4127530A (en) | Novel heneicosapeptides, intermediates therefor and pharmaceutical compositions and methods employing said heneicosapeptides | |
US4127536A (en) | Novel tricosapeptides, intermediates therefor and pharmaceutical compositions and methods employing said tricosapeptides | |
US4127537A (en) | Novel tetracosapeptides, intermediates therefor and pharmaceutical compositions and methods employing said tetracosapeptides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |